Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients

Background: Secondary prevention of hepatocellular carcinoma (HCC) among patients with chronic hepatitis C (CHC) who achieve sustained virologic response (SVR) with interferon-based therapy has been proved effective. However, tertiary prevention with PegIFN/RBV therapy of HCC recurrence seems limite...

Full description

Bibliographic Details
Main Authors: Ying-Chieh Chen, Wei Teng, Yi-Chung Hsieh, Wei-Ting Chen, Wen-Juei Jeng, Chien-Hao Huang, Chen-Chun Lin, Yi-Cheng Chen, Shi-Ming Lin, Chun-Yen Lin, I-Shyan Sheen
Format: Article
Language:English
Published: Elsevier 2019-08-01
Series:Journal of the Formosan Medical Association
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664618306041